Comparative Outcomes of Subtunical Microdissection and Grafting Versus Classical Plaque Incision and Grafting in Complex Peyronie's Disease
Peyronie
1 other identifier
interventional
80
1 country
1
Brief Summary
The goal of this clinical study is to compare two surgical techniques used for the treatment of complex Peyronie's disease. Peyronie's disease can cause penile curvature, deformity, and difficulties during sexual intercourse due to fibrotic plaques within the penile tunica albuginea. In patients with severe deformity, surgical correction is often required. The main question this study aims to answer is whether subtunical microdissection can provide effective correction of penile curvature while preserving erectile function when compared with the classical plaque incision and grafting technique. Participants with complex Peyronie's disease who require surgical correction will undergo either subtunical microdissection or classical plaque incision and grafting. In order to standardize the procedures, the same graft material will be used in both surgical techniques. A bovine pericardial graft will be applied in all cases, and graft size will be determined according to the geometric principles described by Egydio. In the subtunical microdissection technique, the subtunical plane beneath the Peyronie's plaque is carefully dissected using microsurgical instruments under approximately 3.5× optical magnification with surgical loupes. In the classical technique, plaque incision is performed followed by graft reconstruction of the tunical defect. All surgical procedures will be performed by the same surgical team using a standardized operative approach and a uniform anesthesia protocol. Participants will be followed prospectively after surgery to evaluate penile curvature, erectile function, and patient satisfaction. The results of this study may help determine whether subtunical microdissection represents an effective and safe alternative surgical strategy for the treatment of complex Peyronie's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 27, 2025
CompletedFirst Submitted
Initial submission to the registry
March 10, 2026
CompletedFirst Posted
Study publicly available on registry
March 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
July 9, 2026
July 1, 2026
1.3 years
March 10, 2026
July 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Erectile Function
Change in erectile function measured using the International Index of Erectile Function (IIEF-5).The primary outcome of this study is the change in erectile function after Peyronie's disease surgery. The primary outcome of this study is the change in erectile function after Peyronie's disease surgery. Erectile function will be assessed using the International Index of Erectile Function-5 (IIEF-5) questionnaire. The IIEF-5 score ranges from 5 to 25, with higher scores indicating better erectile function. Changes in erectile function will be evaluated by comparing baseline scores with those obtained 6 months after surgery.
Baseline and 6 months after surgery
Successful Penile Straightening
residual curvature \<30° Penile curvature will be assessed in a standardized manner. The degree of curvature will be measured from photographs obtained during erection induced by intracavernosal injection. The angle of curvature will be calculated using digital angle measurement on standardized photographs. The same measurement method will be used at baseline and during postoperative follow-up. To improve consistency and reduce measurement bias, curvature assessment will be performed by an investigator experienced in Peyronie's disease evaluation.
6 months after surgery
Secondary Outcomes (1)
Erection Hardness Score
Baseline and 6 months after surgery
Study Arms (2)
Subtunical Microdissection and Grafting
EXPERIMENTALParticipants with complex Peyronie's disease undergo subtunical microdissection and grafting. The procedure is performed under approximately 3.5× optical magnification using surgical loupes. The subtunical plane beneath the Peyronie's plaque is carefully dissected using microsurgical instruments to release deforming forces while preserving tunical integrity.
Classic Plaque Incision and Grafting
ACTIVE COMPARATORParticipants with complex Peyronie's disease undergo classical plaque incision and grafting surgery. The Peyronie's plaque is incised, and the tunical defect is repaired using graft material to correct penile curvature.
Interventions
Both surgical approaches are performed in patients with complex Peyronie's disease using the same graft material and standardized defect calculation based on geometric principles. In the classical technique, plaque incision is performed followed by graft reconstruction of the tunical defect. In the subtunical microdissection technique, the plaque is approached through careful dissection of the subtunical plane under approximately 3.5× optical magnification using microsurgical instruments in order to release deforming forces while preserving the erectile tissue.
Classical plaque incision and grafting performed in patients with complex Peyronie's disease. After plaque incision, the tunical defect is reconstructed using the same graft material. Defect size is calculated according to standard geometric principles in order to achieve penile straightening.
Eligibility Criteria
You may qualify if:
- \- Male patients aged 18 years or older
- Diagnosis of Peyronie's disease with stable plaque and stable penile curvature for at least 3 months
- Presence of complex Peyronie's disease including severe curvature, multiplanar deformity, hinge effect, hourglass deformity, or large plaques causing functional impairment
- Patients requiring surgical correction with graft-based reconstruction
- Ability to provide informed consent and comply with follow-up evaluations
You may not qualify if:
- Ossified Peyronie's plaques requiring plaque excision
- Congenital penile curvature (congenital chordee)
- Previous penile prosthesis implantation
- Active phase Peyronie's disease with progressive curvature or penile pain
- Severe erectile dysfunction not responsive to medical therapy
- History of prior penile reconstructive surgery
- Significant systemic illness preventing surgical treatment
- Inability to complete postoperative follow-up assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tekirdag Namik Kemal University Faculty of Medicine Hospital
Tekirdağ, 59100, Turkey (Türkiye)
Related Publications (3)
Roadman D, Wang V, Beer A, Levine L. A contemporary assessment of the evaluation and management of patients presenting to a tertiary medical center with Peyronie's disease. Int J Impot Res. 2024 Apr;36(2):118-124. doi: 10.1038/s41443-023-00738-w. Epub 2023 Jul 19.
PMID: 37468535BACKGROUNDKadioglu A, Gurcan M, Rakhmonovich AF, Dursun M. Surgical management of complex curvature in Peyronie's disease. World J Urol. 2024 Apr 30;42(1):276. doi: 10.1007/s00345-024-04936-z.
PMID: 38689034BACKGROUNDEgydio PH, Lucon AM, Arap S. A single relaxing incision to correct different types of penile curvature: surgical technique based on geometrical principles. BJU Int. 2004 Nov;94(7):1147-57. doi: 10.1111/j.1464-410X.2004.05220.x. No abstract available.
PMID: 15541152BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- Number of Participants: 80 Type: Anticipated
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, MD
Study Record Dates
First Submitted
March 10, 2026
First Posted
March 13, 2026
Study Start
May 27, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
July 9, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be available to protect participant privacy.